Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.
Press releases published on October 31, 2025
October 31, 2025
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
Indeterminate
GlobeNewswire
October 31, 2025
IntoCell and Xcellon Biologics Announce MOU to Expand Access to Next-Generation ADC Technologies
Indeterminate
GlobeNewswire
October 31, 2025
Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR
Indeterminate
GlobeNewswire
October 31, 2025
Veru to Present Two Abstracts at ObesityWeek 2025
Indeterminate
GlobeNewswire
October 31, 2025
Disc Medicine to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
October 31, 2025
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
Indeterminate
GlobeNewswire
October 31, 2025
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
Indeterminate
GlobeNewswire
October 31, 2025
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
Indeterminate
GlobeNewswire
October 31, 2025
Certara to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
October 31, 2025
Alps Announces Closing of Business Combination with Globalink Investment Inc.
Indeterminate
GlobeNewswire
October 31, 2025
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
Indeterminate
GlobeNewswire
October 31, 2025
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
Indeterminate
GlobeNewswire
October 31, 2025
Vireo Growth Inc. to Release Third Quarter 2025 Results on November 12, 2025
Indeterminate
GlobeNewswire
October 31, 2025
Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
Indeterminate
GlobeNewswire
October 31, 2025
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
Indeterminate
GlobeNewswire